CHA AI Healthcare Completes 2.5 Billion Won Convertible Bond Issuance to Related Party, Raising Governance and Dilution Concerns
CHA AI Healthcare has completed the issuance of 2.5 billion won in 34th series convertible bonds. This private placement was directed at Cha Care, the largest investor of the largest shareholder, with extremely favorable terms of 0% coupon and 1% maturity interest rate.
The conversion price of 12,463 won significantly exceeds the current stock price of 6,320 won, but it can be adjusted downward to a minimum of 8,725 won based on monthly market prices, creating dilution risk if the stock price rises.
Existing outstanding convertible bonds represent a potential conversion of 4,708,183 shares, equivalent to 25.86% of issued shares, which is expected to weigh heavily on the stock price.
[AI Summary]CHA AI Healthcare secured short-term funding by completing the convertible bond issuance to a related party, but the lack of governance transparency and massive potential dilution negatively impact shareholder value. The possibility of downward conversion price adjustment and uncertainty regarding specific investment use warrant a cautious approach.
KOSPI Filing Information
Result of Issuance of Rights Offering or Equity-Related Bonds (Voluntary Disclosure)